We are live on ! Find out more

759 hedge funds and large institutions have $11.2B invested in Labcorp in 2020 Q1 according to their latest regulatory filings, with 78 funds opening new positions, 269 increasing their positions, 283 reducing their positions, and 112 closing their positions.

New
Increased
Maintained
Reduced
Closed

162% more call options, than puts

Call options by funds: $120M | Put options by funds: $45.7M

5% less repeat investments, than reductions

Existing positions increased: 269 | Existing positions reduced: 283

1.19% less ownership

Funds ownership: 107.02%105.83% (-1.2%)

5% less funds holding

Funds holding: 803759 (-44)

7% less funds holding in top 10

Funds holding in top 10: 1413 (-1)

26% less capital invested

Capital invested by funds: $15.1B → $11.2B (-$3.9B)

30% less first-time investments, than exits

New positions opened: 78 | Existing positions closed: 112

Holders
759
Holders Change
-44
Holders Change %
-5.48%
% of All Funds
16.69%
Holding in Top 10
13
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-7.14%
% of All Funds
0.29%
New
78
Increased
269
Reduced
283
Closed
112
Calls
$120M
Puts
$45.7M
Net Calls
+$73.9M
Net Calls Change
-$34.6M

LH Hedge Fund Activity: Q1 2020 in Review

759 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q1 2020, worth a combined $11.2B — down 26% from $15.1B a quarter earlier.

Sellers outnumbered buyers: 112 funds closed out of LH and 78 opened new positions — a net loss of 34 holders — while 283 trimmed existing stakes and 269 added.

The largest buyer was Melvin Capital Management, adding an estimated $184M. The largest seller was Champlain Investment Partners, exiting entirely with an estimated $132M sold.

  • 759 institutional investors held Labcorp (LH) as of Q1 2020, down from 803 in Q4 2019.
  • Funds reported $11.2B of Labcorp stock for Q1 2020, down 26% quarter-over-quarter.
  • 78 funds opened new Labcorp positions in Q1 2020 and 112 closed out, a net change of -34 holders.
  • The largest Labcorp buyer in Q1 2020 was Melvin Capital Management, an estimated $184M added.
  • The largest Labcorp seller in Q1 2020 was Champlain Investment Partners, an estimated $132M sold.

Based on aggregated 13F filings for Q1 2020.